Ebola vaccine promising in first human trials ----NIH

By -
 
Researchers say they’re a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field, reports The Himalayan Times.
The news comes amid the worst ever outbreak of the haemorrhagic fever, which has killed nearly 5,700 people, mostly in West Africa.
Pharmaceutical companies and health agencies are scrambling to fast-track experimental drugs and vaccines that could help.
In the first phase of testing, all 20 healthy adults injected with a higher or lower dose of the vaccine developed antibodies needed to fight Ebola, said the National Institutes of Health, which conducted the study.
Results were published yesterday in the New England Journal of Medicine.
“The unprecedented scale of the current Ebola outbreak in West Africa has intensified efforts to develop safe and effective vaccines,” said Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, which is developing the vaccine alongside GlaxoSmithKline.
The vaccines under development “may play a role in bringing this epidemic to an end and undoubtedly will be critically important in preventing future large outbreaks,” he noted.
“Based on these positive results from the first human trial of this candidate vaccine, we are continuing our accelerated plan for larger trials to determine if the vaccine is efficacious in preventing Ebola infection,” he added.
But the NIAID/GSK vaccine is still a long way from being ready for use in the field.
The NIAID is “in active discussions with Liberian officials and other partners about next-stage vaccine testing in West Africa” for efficacy and safety, the NIH said, but no announcement on larger-scale trials was expected before early next year.
There is no licensed treatment or vaccine against the Ebola virus, which is transmitted through bodily fluids and has been fatal in an estimated 70 per cent of cases in the current outbreak.
Antibodies within four weeks
The volunteers were injected starting in September, and each showed a positive result for Ebola antibodies in blood tests within four weeks. The 10 volunteers in the higher-dose group developed higher antibody levels, the NIH said. In addition, two of the lower-dose group and seven of the higher-dose group developed a kind of immune cell called CD8 T cells, which are an important part of the body’s response against disease.
“We know from previous studies in non-human primates that CD8 T cells played a crucial role in protecting animals” who got the vaccine and then were exposed to Ebola, said researcher Julie Ledgerwood, the trial’s principal investigator. None of the volunteers experienced serious side effects within the study period, though two had a brief, mild fever within the 24 hours after the injection.

Comments

Post a Comment

Popular posts from this blog

UBTH @50: Obaseki hails institution’s role in strengthening Edo healthcare

By -
Image
(Nigeria) Governor Godwin Obaseki of Edo State, has commended the staff and management of the University of Benin Teaching Hospital, UBTH, for their unwavering commitment, dedication, and hard work in providing high-quality healthcare services to the people of Edo State and Nigeria in the past fifty years. Obaseki, at a dinner organized in honour of the Committee of Chief Medical Directors of Nigeria, at the Government House, Benin City, reassured the government’s continuous partnership and collaboration with the federal government-owned health institution to strengthen the health system and ensure quality health delivery to Edo people. The governor, who was represented by his deputy, Philip Shaibu, reeled out the gains of the government’s reforms in the health sector, commending the medical centre for bolstering the government’s efforts at transforming Edo State into a health hub. He said, "We came into a wilderness where you have to cut a part for yourself and fix it. We held
Read more

NBC has no powers to impose fine on broadcast stations --Court

By -
Image
(Nigeria) The National Broadcasting Commission, NBC, has been restrained by a Federal High Court sitting in Abuja, from imposing fines on broadcast stations in the country. Trial judge in the matter, Justice James Omotosho also set aside the N500,000 fines imposed on March 1, 2019, on each of 45 broadcast stations. The court made the orders in its judgment a suit by the Incorporated Trustees of Media Rights Agenda, MRA, which had sued the NBC. Justice Omotosho held that the NBC, not being a court of law, had no power to impose sanctions as punishment on broadcast stations. The court further held that the Nigeria Broadcasting Code, which gives the commission the power to impose sanction, is in conflict with Section 6 of the Constitution that vested judicial power in the court of law. He said the court would not sit idle and watch a body imposing fine arbitrarily without recourse to the law. He said that the commission did not comply with the law when it sat as a complainant and at
Read more